Rachel Chambers on Muck Rack

Rachel Chambers

Verified
London
As seen in: European Respiratory Review, Nature, SAGE Publishing, Thorax, Science Magazine, The New England Journal of Medicine, Leafly, European Respiratory Journal, LG Focus
PhD student @csi_kcl | YA palliative care | Graduate of @MentalhealthMSc | Views are my own
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rachel

Contact Rachel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models - Nature Communications

|
By DArcy Wagner, Hani N. Alsafadi, Qianjiang Hu, Claudia A. Staab-Weijnitz, Martina Korfei, Nika Gvazava, Kristin Wannemo, Adriana Estrada-Bernal, Juan D Cala-Garcia, Juan David Cala-García, Rita Medina Costa, Rita de Cássia Costa, John Stegmayr, Wioletta Skronska-Wasek, Jingtao Wang, John Sembrat, Anne Hilgendorff, Jun Ding, Andreas Günther, Rachel Chambers Verified, Naftali Kaminski, Mareike Lehmann, Oliver Eickelberg, Nilay Mitash, Katrin Mutze, Stijn de Langhe
| Nature Verified
Abstract Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal disease characterized by excessive extracellular matrix deposition. Current IPF therapies slow disease progression but do not stop or reverse it. The (myo)fibroblasts are thought to be the main cellular contributors to excessive extracellular matrix production in IPF. Here we show that fibrotic alveolar type II cells regulate production and crosslinking of extracellular matrix via the co-transcriptional activator YAP.
Open in Who Shared Issue with article?

Evaluating the measurement properties of patient-reported outcome measures for young adults with life-limiting conditions: A systematic review

|
By Rachel Chambers Verified, Mevhibe B Hocaoglu, Irene Higginson, Katherine Sleeman
| SAGE Publishing
What is already known about the topic? • Patient reported outcome measures can facilitate communication, allowing patients to report their needs, symptoms and concerns to healthcare professionals and providing an opportunity to address unmet needs, leading to improved care. • Young adults (aged 18–25 years) living with life-limiting conditions are a heterogeneous population, with a range of unique needs which are often unmet. What this paper adds?
Open in Who Shared Issue with article?

Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature

|
By Kaylee B. Worlock, Lisa M Dratva, Masahiro Yoshida, Helen R. Wagstaffe, Laura Richardson, Josephine Barnes, Lorenz Kretschmer, Krzysztof Polanski, Jessica Allen-Hyttinen, Puja A. Mehta, Jacqueline M. Boccacino, Waradon Sungnak, Rasa Elmentaite, Ni Huang, Rakesh Kapuge, Liam Bolt, Elena Prigmore, Leo Swadling, Claire Smith, Vitor H. Teixeira, Vítor Teixeira, Sam M. Janes, Rachel Chambers Verified, Muzlifah Haniffa, Robert S Heyderman, Mahdad Noursadeghi, Benny Chain, Andreas Mayer, Kerstin B Meyer, Christopher J Chiu, Marko Nikolic
| Nature Verified
Correction to: Nature https://doi.org/10.1038/s41586-024-07575-x Published online 19 June 2024 In the version of the article initially published, the Acknowledgements was missing the following text, which has now been added to the HTML and PDF versions of the article: “The authors gratefully acknowledge support from the UK Vaccine Taskforce of the Department of Business, Energy and Industrial Strategy of Her Majesty’s Government (BEIS).
Open in Who Shared Issue with article?
See all 18 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified